Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter
Ferrat LA, Templeman EL, Steck AK, et al.
Diabetologia. Pub. online 10 May 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Continuous glucose monitoring as equinox of nocturnal and daytime hypoglycaemia in type 1 diabetes: insights from the randomized controlled HypoDE trial
Hermanns N, Heinemann L, Kulzer B, et al.
Diabetes Res Clin Pract. 2025:112228.
Leggi
Time in tight range and time in range for predicting the achievement of typical glucose management indicator and HbA1c targets
Kim S, Park SH, Lee JA, et al.
Diabetologia. Pub. online 7 May 2025.
Leggi
The efficacy of intermittent scanning continuous glucose monitoring in the elderly: a case-control study
Been RA, van Helsdingen MRX, Zammit D, et al.
Diabetes Obes Metab. Pub. online 13 May 2025.
Leggi
Application of the C-reactive protein-triglyceride glucose index in predicting the risk of new-onset diabetes in the general population aged 45 years and older: a national prospective cohort study
Shan Y, Liu Q, Gao T
BMC Endocr Disord. 2025;25(1):126.
Leggi
Stability and impact of diabetes distress over time: the potential value and uses of the type 1 diabetes distress assessment system (T1-DDAS)
Hessler DM, Polonsky WH, Strycker L, et al.
Diabet Med. 2025:e70066.
Leggi
Effect of different types of coffee consumption on the risk of cardiovascular complications and related mortality events in prediabetes: an analysis from NHANES
Yang D, Mao Y, Chen S, et al.
Nutr Metab Cardiovasc Dis. Pub. online 8 May 2025.
Leggi
Influence of glucagon-like peptide-1 receptor agonists on renal parameters: a meta-analysis of randomized controlled trials
Li W, Liang X, Sun N, Zhang D
BMC Endocr Disord. 2025;25(1):124.
Leggi
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
Bensaaud A, Seery S, Gibson I, et al.
Cochrane Database Syst Rev. 2025;5(5):CD013729.
Abstract
Leggi
Cellular versus acellular matrix products for diabetic foot ulcer treatment: the Dermagraft and Oasis Longitudinal Comparative Efficacy Study (DOLCE) – a randomized clinical trial
Shawa H, Kaur R, Tchanque-Fossuo C, et al.
Diabetes Care. 2025:dc241233.
Leggi